The intent of this timely collection of essays is captured in the cover illustration by Jo Spence: a surgical team peer over their masks at the photographer on the operating table, the surgeon's lurid orange gloves held aloft in preparation, as the patient turns the camera's gaze back in his direction. The historiographical approach is bookended by the editors’ introductory suggestion that the scholarship should likewise reorient its perspective, and by John Pickstone's concluding remarks on the utility of reinstating the idea of the patient as a patron in the pursuit of relevant contemporary history.
The individual with cancer has been a relatively shadowy presence in the recent historiography of the disease. Siddharta Mukherjee's publishers might argue that patients are central to his recent history, The Emperor of All Maladies, but his patients are the supporting cast, brought onstage to illustrate the heroic achievements of doctors and medical science. Of course, social histories of medicine have long challenged the doctor-centric version of events. The desire to unpick the narrative of inevitable progress, and the idea of cancer's history as an infinitely complex, contested construction, shaped by multiple players, is now well established, not least by the earlier work of contributors to this volume. This work has included the mounting acknowledgement of how groups of patients – and patients-in-waiting – work as historical agents in, for example, recent histories of cancer control and prevention. These histories have considered how people influenced by cancer metaphors, cultural representations and narratives of ‘hope and progress’ have resisted, subverted or confounded the efforts of doctors and policy-makers.
Part II of the volume, grouped under the heading of ‘Pathways’, shares this approach, with groups of patients framed as important influences on treatment pathways, cancer research and therapeutic innovation. In her chapter ‘Uncertain enthusiasm: PSA screening, proton therapy and prostate cancer’, Helen Valier discusses the role of the health consumer – under the influence of narratives of ‘early detection’, and politicized by health activists – in creating a market for an expensive new therapy, undermining the usual requirements for evidence generated in clinical trials. Alberto Cambrosio and Peter Keating, in ‘Cancer research and protocol patients: from clinical material to committee advisors’, discuss the role of cancer patient activism in the design and conduct of cancer clinical trials, and the recruitment of patients to them, and the shift from adversary to collaborator that took place from the early 1980s onwards.
In other instances, patient choice is influential but vulnerable to prevailing cultures of ‘certainty’ and ‘evidence’ even when that evidence is contested. Illana Löwy considers the shifting opinions on conservative treatments of breast cancer, which suited the women concerned, persuaded their doctors and seemed to produce favourable results, but which were vulnerable to doctors’ own uncertainties and preferences for ‘doing “everything possible”, whatever the price for the patient’ (p. 123). Elizabeth Toon, in ‘Measured responses: British clinical researchers and therapies for advanced breast cancer in the 1960s and 1970s’, discusses how individual subjective assessments of quality of life in experimental therapies for advanced disease collided with the trend towards standardization and objectivity that was increasingly the focus of randomized controlled trials. Although significant for individual clinician assessments, questions of subjectivity and patient preference were gradually confined to the sidelines, in ‘letters to the editor’ and other such ‘philosophical musings’ (p. 151).
But it is perhaps Part I of the volume – under the heading of ‘Patients’ – that rises to Jo Spence's challenge most effectively. Joanna Baines uses her own family experience of three generations of breast cancer to chart the establishment of the ‘cancer culture’ and to challenge what we might assume to be its benefits for the individual. Baines describes the progressive historical colonization of the cancer diagnosis on one's life and identity, and the problematic shift from external to internal determinants of outcome. Carsten Timmermann has used an illness narrative written by Mary Craig, describing her husband Frank's experience of lung cancer, to explore concepts of ‘hope’ and ‘progress’ in a setting conceived by doctors as unremittingly bleak. This essay is a reminder that although patients’ expectations are influenced by doctors, who dictate the terms based on their experience of collective pathways, patients have only one, unique pathway. They will define what constitutes progress or palliation and these definitions are fluid and contingent. In ‘Captain Chemo and Mr Wiggly: patient information for children with cancer in the late twentieth century’, Emma Barnes Johnson considers the hitherto overlooked historical source of patient information materials. In their contributions as authors and editors, children and young people with cancer were to exert a powerful influence on their peers, reframing the experience of childhood cancer for a new audience. Gerard Kutcher, in ‘A case study in human experimentation: the patient as subject, object and victim’, uses the example of Maude Jacobs, a participant in what would become the notorious US Defence Department research into total body irradiation, to argue that attention to individual examples allows a case study to capture the chasm of experience between the reports of medical researchers and the perspectives of research participants.
In placing the choices, subjective experiences and individual voices of people with cancer in the foreground, this collection offers a more nuanced reading of the contingencies and politics of care pathways, the ethical tensions between collective and individual, and the blurred distinctions between experimental and therapeutic. The rhetoric of the NHS has for some time encouraged us to believe that the patient is at the centre of the design and provision of health care. It is necessary that our histories are likewise patient-centred, lest we lose sight of what is at stake. As individuals in the clinic collaborating in decision-making, as people attempting to negotiate life with the diagnosis, as collective activists, or simply in their capacity to choose and resist the standardizing efforts of modern biomedicine, people with cancer are a powerful presence in recent history. This volume is, at long last, a contribution to the historiography that manages to liberate individuals from the generic category of ‘the patient’ and relieve them of service to histories created by others. After all, this is a history that we all stand a good chance of contributing to.
